| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MRC Human Reproductive Sciences Unit and Reproductive and Developmental Sciences, University of Edinburgh, Centre for Reproductive Biology, The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, United Kingdom
* To whom correspondence should be addressed. E-mail: h.jabbour{at}hrsu.mrc.ac.uk.
In women, endometrial morphology and function undergo characteristic changes every menstrual cycle. These changes are crucial for perpetuation of the species and are orchestrated to prepare the endometrium for implantation of a conceptus. In the absence of pregnancy, the human endometrium is sloughed off at menstruation over a period of a few days. Tissue repair, growth, angiogenesis, differentiation and receptivity ensue to prepare the endometrium for implantation in the next cycle. Ovarian sex steroids through interaction with different cognate nuclear receptors regulate the expression of a cascade of local factors within the endometrium that act in an autocrine/paracrine and even intracrine manner. Such interactions initiate complex events within the endometrium that are crucial for implantation and, in the absence thereof, normal menstruation. A clearer understanding of regulation of normal endometrial function will provide an insight into causes of menstrual dysfunction such as menorrhagia (heavy menstrual bleeding) and dysmenorrhea (painful periods). The molecular pathways that precipitate these pathologies remain largely undefined. Future research efforts to provide greater insight into these pathways will lead to the development of novel drugs that would target identified aberrations in expression and/or of local uterine factors that are crucial for normal endometrial function.
This article has been cited by other articles:
![]() |
X. Fan, S. Krieg, C. J. Kuo, S. J. Wiegand, M. Rabinovitch, M. L. Druzin, R. M. Brenner, L. C. Giudice, and N. R. Nayak VEGF blockade inhibits angiogenesis and reepithelialization of endometrium FASEB J, October 1, 2008; 22(10): 3571 - 3580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Labied, C. Galant, M. Nisolle, S. Ravet, C. Munaut, E. Marbaix, J.-M. Foidart, and F. Frankenne Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time Hum. Reprod., September 23, 2008; (2008) den339v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bombail, S. MacPherson, H. O.D. Critchley, and P. T.K. Saunders Estrogen receptor related beta is expressed in human endometrium throughout the normal menstrual cycle Hum. Reprod., September 4, 2008; (2008) den298v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Fraser, H. Wilson, A. Silvestri, K. D. Morris, and S. J. Wiegand The Role of Vascular Endothelial Growth Factor and Estradiol in the Regulation of Endometrial Angiogenesis and Cell Proliferation in the Marmoset Endocrinology, September 1, 2008; 149(9): 4413 - 4420. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zicari, C. Centonze, M. Realacci, B. Buchetti, A. Pietropolli, and C. Ticconi Estradiol 17-{beta} and Progesterone Modulate Inducible Nitric Oxide Synthase and High Mobility Group Box 1 Expression in Human Endometrium Reproductive Sciences, July 1, 2008; 15(6): 559 - 566. [Abstract] [PDF] |
||||
![]() |
N. Kane, M. Jones, J. J. Brosens, P. T. K. Saunders, R. W. Kelly, and H. O. D. Critchley Transforming Growth Factor-{beta}1 Attenuates Expression of Both the Progesterone Receptor and Dickkopf in Differentiated Human Endometrial Stromal Cells Mol. Endocrinol., March 1, 2008; 22(3): 716 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bai, G. Grossman, L. Yuan, B. A. Lessey, F. S. French, S. L. Young, and E. M. Wilson Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation Mol. Hum. Reprod., February 1, 2008; 14(2): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, K. Mah, R.S. Carroll, O.D. Slayden, and R.M. Brenner Progesterone withdrawal up-regulates fibronectin and integrins during menstruation and repair in the rhesus macaque endometrium Hum. Reprod., December 1, 2007; 22(12): 3223 - 3231. [Abstract] [Full Text] [PDF] |
||||
![]() |
The ESHRE Capri Workshop Group Endometrial bleeding Hum. Reprod. Update, September 1, 2007; 13(5): 421 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.D. Catalano, H.O. Critchley, O. Heikinheimo, D.T. Baird, D. Hapangama, J.R.A. Sherwin, D.S. Charnock-Jones, S.K. Smith, and A.M. Sharkey Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium Mol. Hum. Reprod., September 1, 2007; 13(9): 641 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Silvestri and H. M Fraser Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy Reproduction, August 1, 2007; 134(2): 341 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, C. Zhu, H. Lin, Q. Yang, Q. Ou, Y. Li, Z. Chen, P. Racey, S. Zhang, and H. Wang Wild Fulvous Fruit Bats (Rousettus leschenaulti) Exhibit Human-Like Menstrual Cycle Biol Reprod, August 1, 2007; 77(2): 358 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wanggren, P.G. Lalitkumar, F. Hambiliki, B. Stabi, K. Gemzell-Danielsson, and A. Stavreus-Evers Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo Mol. Hum. Reprod., June 1, 2007; 13(6): 391 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Niklaus, M. Aubuchon, G. Zapantis, P. Li, H. Qian, B. Isaac, M. Y. Kim, G. Adel, J. W. Pollard, and N. F. Santoro Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women Hum. Reprod., June 1, 2007; 22(6): 1778 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-w. Cheng, H. Bielby, D. Licence, S. K. Smith, C. G. Print, and D. S. Charnock-Jones Quantitative Cellular and Molecular Analysis of the Effect of Progesterone Withdrawal in a Murine Model of Decidualization Biol Reprod, May 1, 2007; 76(5): 871 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chegini, X. Luo, Q. Pan, A. Rhoton-Vlasak, and D.F. Archer Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy Hum. Reprod., February 1, 2007; 22(2): 427 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M Fraser, H. Wilson, C. Wulff, J. S Rudge, and S. J Wiegand Administration of vascular endothelial growth factor Trap during the 'post-angiogenic' period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset. Reproduction, October 1, 2006; 132(4): 589 - 600. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Milling Smith, S. Battersby, K. J. Sales, H. O. D. Critchley, and H. N. Jabbour Prostacyclin Receptor Up-Regulates the Expression of Angiogenic Genes in Human Endometrium via Cross Talk with Epidermal Growth Factor Receptor and the Extracellular Signaling Receptor Kinase 1/2 Pathway Endocrinology, April 1, 2006; 147(4): 1697 - 1705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |